References

1. ModernaCOVID-19 vaccine. (2021). Accessed: February 14, 2021: https://www.fda.gov/emergencypreparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine.
2. Clinical trial results. (2021). Accessed: February 13,2021: https://www.modernatx.com/covid19vaccineeua/providers/clinical-trial-data.
3. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS: Neurological complications ofCOVID- 19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021, 13:13426. 10.7759/cureus.13426
4. Shimabukuro T: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTechCOVID-19 vaccine - United States, December 14-23. MMWR Morb Mortal Wkly Rep. 2021, 70:46-51.10.15585/mmwr.mm7002e1.
5. Grienacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P., Eichinger S. A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia following coronavirus-19 vaccination. Res Square. 2021 doi: 10.21203/rs.3.rs-362354/v1. [CrossRef] [Google Scholar]
6. Boivin Z., Martin J. Untimely myocardial infarction orCOVID-19 vaccine side effect. Cureus. 2021;13 [PMC free article] [PubMed] [Google Scholar]
7. Merchant H. COVID vaccines and thrombotic events: is mRNA translation and spike protein synthesis by platelets a real possibility? BMJ. 2021 https://www.bmj.com/content/372/bmj.n699/rr-20 [Google Scholar]
8. Kounis N.G., Mazarakis A., Tsigkas G., Giannopoulos S., Goudevenos J. Kounis syndrome: a new twist on an old disease. Future Cardiol. 2011;7:805–824. [PubMed] [Google Scholar]
9. Kounis N.G., Koniari I., de Gregorio C., Velissaris D., Petalas K., Brinia A. Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines. 2021;9:221. doi: 10.3390/vaccines9030221. [PMC free article] [PubMed] [CrossRef] [Google Scholar].

Corresponding Author

Dr Shashikant Singh

DM Cardiology 2nd Year, Dept of Cardiology, AIIMS Bhubaneswar